SCHEMBL22452933

SCHEMBL22452933

COC(=O)c1cccc(Nc2cccc(Nc3ccc(C4CCCCC4)cc3Cl)c2)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX3 P56373 2/20 0.39
CDK5 Q00535 1/20 0.38
DYRK1A Q13627 1/20 0.38
CDK5R1 Q15078 1/20 0.38
GRM5 P41594 1/20 0.37
CNR2 P34972 2/20 0.37
CNR1 P21554 1/20 0.37
BRAF P15056 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
MAPT P10636 1/20 0.36
ROCK1 Q13464 1/20 0.36
ABL1 P00519 1/20 0.36
PTGES O14684 1/20 0.36
ALOX5 P09917 1/20 0.36
DHODH Q02127 1/20 0.36
EGLN1 Q9GZT9 1/20 0.35
GRM4 Q14833 1/20 0.35
SERPINE1 P05121 1/20 0.35
NPC1 O15118 1/20 0.35
TP53 P04637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22453348 0.89 KMT2A (0.42) CNR2CNR1BRAFSMN1; SMN2ABL1
SCHEMBL22452937 0.83 DHODH (0.40) P2RX3MAPTDHODHTP53CYP1A2
SCHEMBL22453715 0.82 GAA (0.38) MAPTDHODHTP53CYP1A2
SCHEMBL22453088 0.81 DHODH (0.42) SMN1; SMN2PTGESALOX5DHODHEGLN1
SCHEMBL22452817 0.80 KDM1A (0.42) SMN1; SMN2MAPTPTGESALOX5DHODH
SCHEMBL22452643 0.76 CNR2 (0.46) CNR2BRAFMAPTNPC1CYP1A2
SCHEMBL22452645 0.75 KDM1A (0.37) CNR2BRAFALOX5DHODH
SCHEMBL22453372 0.74 GAA (0.49) SMN1; SMN2MAPTDHODHSERPINE1
SCHEMBL22452646 0.73 SERPINE1 (0.50) SMN1; SMN2MAPTPTGESGRM4SERPINE1
SCHEMBL22453062 0.73 DHODH (0.52) SMN1; SMN2MAPTDHODHSERPINE1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020190774-A1 NOVEL SMALL MOLECULE INHIBITORS OF TEAD TRANSCRIPTION FACTORS THE GENERAL HOSPITAL CORPORATION (US) 2020-09-24 WO disclosed